Oncorena AB
Quotes
Share:
Subscribe:

Lars Grundemar CEO Oncorena AB

Mon, Mar 01, 2021 08:00 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden Tue, Feb 01, 2022 07:45 CET

Oncorena Secures Financing of the Company’s Continued Development of Orellanine, a Potential Breakthrough Therapy for Advanced Renal Cancer Thu, Dec 23, 2021 07:30 CET